Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan H Griffin

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Protocols|October 15, 2024
Genetic Modification of Mice Using Prime EditingAmr R Salem, Xiaoling Xie, Susan H Griffin, et al.
Vascular Pharmacology|December 29, 2023
Prime editing in mice with an engineered pegRNAAmr R Salem, W Bart Bryant, Jaser Doja, et al.
The CRISPR Journal|April 18, 2023
CRISPR-Cas9 Long-Read Sequencing for Mapping Transgenes in the Mouse GenomeW Bart Bryant, Allison Yang, Susan H Griffin, et al.
BMC Biology|July 2, 2025
Development and characterization of a fully humanized ACE2 mouse modelChunyu Ge, Amr R Salem, Amany Elsharkawy, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Loss of the Coronary Artery Disease Risk Gene <i>Leiomodin1</i> in Vascular Smooth Muscle Cells Triggers Rapid Onset Coronary AtherosclerosisAmr R Salem, Jaser Doja, Chunyu Ge, et al.
Nature Cardiovascular Research|November 25, 2022
Generation and Comparative Analysis of an <i>Itga8-CreER</i> <sup></sup> Mouse with Preferential Activity in Vascular Smooth Muscle CellsGanesh Warthi, Jessica L Faulkner, Jaser Doja, et al.
Nature Cardiovascular Research|August 28, 2024
Author Correction: Generation and comparative analysis of an Itga8-CreER<sup>T2</sup> mouse with preferential activity in vascular smooth muscle cellsGanesh Warthi, Jessica L Faulkner, Jaser Doja, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Protocols|October 15, 2024
Genetic Modification of Mice Using Prime EditingAmr R Salem, Xiaoling Xie, Susan H Griffin, et al.
Vascular Pharmacology|December 29, 2023
Prime editing in mice with an engineered pegRNAAmr R Salem, W Bart Bryant, Jaser Doja, et al.
The CRISPR Journal|April 18, 2023
CRISPR-Cas9 Long-Read Sequencing for Mapping Transgenes in the Mouse GenomeW Bart Bryant, Allison Yang, Susan H Griffin, et al.
BMC Biology|July 2, 2025
Development and characterization of a fully humanized ACE2 mouse modelChunyu Ge, Amr R Salem, Amany Elsharkawy, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Loss of the Coronary Artery Disease Risk Gene <i>Leiomodin1</i> in Vascular Smooth Muscle Cells Triggers Rapid Onset Coronary AtherosclerosisAmr R Salem, Jaser Doja, Chunyu Ge, et al.
Nature Cardiovascular Research|November 25, 2022
Generation and Comparative Analysis of an <i>Itga8-CreER</i> <sup></sup> Mouse with Preferential Activity in Vascular Smooth Muscle CellsGanesh Warthi, Jessica L Faulkner, Jaser Doja, et al.
Nature Cardiovascular Research|August 28, 2024
Author Correction: Generation and comparative analysis of an Itga8-CreER<sup>T2</sup> mouse with preferential activity in vascular smooth muscle cellsGanesh Warthi, Jessica L Faulkner, Jaser Doja, et al.
Pageof 1